A detailed history of Camden Capital, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Camden Capital, LLC holds 14,712 shares of HBIO stock, worth $31,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,712
Previous 14,700 0.08%
Holding current value
$31,483
Previous $41,000 4.88%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.64 - $3.54 $31 - $42
12 Added 0.08%
14,712 $39,000
Q2 2024

Aug 06, 2024

BUY
$2.77 - $4.63 $900 - $1,504
325 Added 2.26%
14,700 $41,000
Q3 2023

Nov 03, 2023

BUY
$4.0 - $5.82 $140 - $203
35 Added 0.24%
14,375 $61,000
Q3 2022

Nov 08, 2022

SELL
$2.33 - $3.92 $58,156 - $97,843
-24,960 Reduced 63.51%
14,340 $37,000
Q2 2022

Aug 03, 2022

BUY
$3.28 - $6.42 $3,280 - $6,420
1,000 Added 2.61%
39,300 $141,000
Q2 2021

Aug 16, 2021

BUY
$5.44 - $8.4 $208,352 - $321,720
38,300 New
38,300 $319,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.